166
Participants
Start Date
November 22, 2020
Primary Completion Date
May 7, 2024
Study Completion Date
September 24, 2024
Cytoflavin ((Inosine + Nicotinamide + Riboflavin + Succinic Acid)
20 ml (2 ampoules, 10 ml each) dissolved in 200 ml of 0.9% sodium chloride, intravenously 2 times a day with an interval of 12 ± 2 hours, for 10 days.
Placebo
20 ml of 0.9% sodium chloride (2 ampoules of 10 ml each), added to 200 ml of 0.9% sodium chloride, intravenously 2 times a day with an interval of 12 ± 2 hours, for 10 days
City Hospital of the Holy Martyr Elizabeth, Saint Petersburg
West Kazakhstan Medical University named after. M. Ospanov, Aktobe
Ivanovskaya Regional Clinical Hospital, Ivanovo
City Clinical Hospital No. 67 named after L.A. Vorokhobov, Moscow
Research Institute of Emergency Medicine n.a. N.V. Sklifosovsky, Moscow
Nizhny Novgorod Regional Clinical Hospital named after N.A. Semashko, Nizhny Novgorod
Stavropol Regional Clinical Hospital, Stavropol
"State Autonomous Healthcare Institution of the Sverdlovsk Region Central City Clinical Hospital No. 23", Yekaterinburg
POLYSAN Scientific & Technological Pharmaceutical Company
INDUSTRY